93
Participants
Start Date
August 26, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
February 28, 2026
Obexelimab
Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcyRIIb, resulting in down regulation of B cell activity
Placebo
Placebo
University of South Florida, Tampa
North Central Neurology, Cullman
Aqualine Clinical Research, Naples
Boster Center for MS, Columbus
Medical College of Wisconsin, Milwaukee
Center for Neurological Disorders, Greenfield
Infusion Associates Plymouth, Plymouth
MS Center for Innovations in Care, St Louis
North Texas Institute of Neurology and Headache, Plano
Center for Neurology and Spine, Phoenix
Perseverance Research Center, Scottsdale
Regina Berkovich MD PhD, Inc, West Hollywood
University of Massachusetts Medical School, Worcester
Holy Name Medical Center, Teaneck
Neuro-logisch Wien, Vienna
Rehabilitation & MS Center, Noorderhart Hospital, Overpelt
AZ Delta-Deltalaan 1, Roeselare
Tiantan Hospital, Capital Medical University, Beijing
The First Affiliation Hospital of Soochow University, Suzhou
Tianjin Medical University General Hospital, Tianjin
People's Hospital of Xinjiang Uyaur Autonomous Region, Ürümqi
Tongji Hospital, Tongji Medical Center of HUST, Wuhan
Klinicki bolnicki centar Zagreb, Zagreb
Fakultni nemocnice u sv. Anny v Brne, Brno
Nemocnice Jihlava, Jihlava
General University Hospital Praha, Prague
Aalborg Universitetshospital, Aalborg
Attikon University General Hospital, Chaïdári
University General Hospital of Larissa, Larissa
Fondazione Isituto G. Giglio di Cefalu, Cefalù
University of Florence, Florence
Istituto Neurologico Mediterraneo Neuromed, Pozzilli
Fondazione PTV Policlinico Tor Vergata, Roma
Neurocentrum Bydgoszcz sp.z o.o., Bydgoszcz
M.A. LEK A.M. Maciejowsy Spolka Cywilna, Katowice
Zanamed Medical Clinic Sp z o.o., Lublin
Wielospecjalistyczne Centrum Medyczne Ibismed, Zabrze
Hospital Clinico San Carlos, Madrid
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Regional Universitario de Malaga - Hospital General, Málaga
Hospital Regional Universitario de Malaga, Málaga
Hospital Universitario Virgen de La Arrixaca, Murcia
Hospital Virgen Macarena, Seville
Hospipal La Fe Valencia, Valencia
Leicester General Hospital, Leicester
Barts Health NHS Trust, London
Morriston Hospital, Swansea
Zenas BioPharma (USA), LLC
INDUSTRY